International Journal of Cardiology
Volume 143, Issue 2 , Pages 147-153 , 20 August 2010

Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in elderly patients transferred with ST-elevation myocardial infarction: Data from the EUROTRANSFER registry

  • Artur Dziewierz

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • ,
  • Zbigniew Siudak

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • ,
  • Tomasz Rakowski

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • ,
  • Michał Chyrchel

      Affiliations

    • Department of Interventional Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • ,
  • Waldemar Mielecki

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • ,
  • Magnus Janzon

      Affiliations

    • Department of Cardiology, Linköping University Hospital, Sweden
    • ,
  • Ralf Birkemeyer

      Affiliations

    • Department of Cardiology, Schwarzwald-Baar Klinikum Villingen-Schwenningen, Germany
    • ,
  • Ilkka Tierala

      Affiliations

    • Department of Cardiology, University Hospital, Helsinki, Finland
    • ,
  • Roman M. Wojdyła

      Affiliations

    • Department of Interventional Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • ,
  • Jacek S. Dubiel

      Affiliations

    • 2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • ,
  • Dariusz Dudek

      Affiliations

    • Department of Interventional Cardiology, Jagiellonian University Medical College, Krakow, Poland
    • Corresponding Author InformationCorresponding author. Department of Interventional Cardiology, Jagiellonian University Medical College, Kopernika 17 Street, 31-501 Krakow, Poland. Tel.: +48 12 424 71 81; fax: +48 12 424 71 84.

Received 6 August 2008 ,Revised 28 January 2009 ,Accepted 6 February 2009.

References 

  1. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). Circulation. 2004;110:e82–e292
  2. De Luca G, Suryapranata H, Stone GW, et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA. 2005;293:1759–1765
  3. Montalescot G, Antoniucci D, Kastrati A, et al. Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up. Eur Heart J. 2007;28:443–449
  4. Rakowski T, Zalewski J, Legutko J, et al. Early abciximab administration before primary percutaneous coronary intervention improves infarct-related artery patency and left ventricular function in high-risk patients with anterior wall myocardial infarction: a randomized study. Am Heart J. 2007;153:360–365
  5. Godicke J, Flather M, Noc M, et al. Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studies. Am Heart J. 2005;150:1015
  6. Bellandi F, Maioli M, Leoncini M, Toso A, Dabizzi RP. Early abciximab administration in acute myocardial infarction treated with primary coronary intervention. Int J Cardiol. 2006;108:36–42
  7. Maioli M, Bellandi F, Leoncini M, Toso A, Dabizzi RP. Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx–AMI Trial). J Am Coll Cardiol. 2007;49:1517–1524
  8. De Luca G, Gibson M, Bellandi F, et al. Early Glycoprotein IIb-IIIa inhibitors in Primary angioplasty (EGYPT) cooperation. An individual patient's data meta-analysis. Heart. 2008;94:548–558
  9. Guagliumi G, Stone GW, Cox DA, et al. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. Circulation. 2004;110:1598–1604
  10. Alexander KP, Newby LK, Armstrong PW, et al. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on clinical cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 2007;115:2570–2589
  11. Dudek D, Siudak Z, Janzon M, et al. European Registry on patients with st-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab — EUROTRANSFER Registry. Am Heart J. 2008;156:1147–1154
  12. Prasad A, Stone GW, Aymong E, et al. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. Am Heart J. 2004;147:669–675
  13. De Luca G, van 't Hof AW, Ottervanger JP, et al. Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Eur Heart J. 2005;26:662–666
  14. DeGeare VS, Stone GW, Grines L, et al. Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials). Am J Cardiol. 2000;86:30–34
  15. Batchelor WB, Anstrom KJ, Muhlbaier LH, et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7472 octogenarians. National Cardiovascular Network Collaboration. J Am Coll Cardiol. 2000;36:723–730
  16. Yan AT, Yan RT, Tan M, et al. Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromes. Can J Cardiol. 2006;22:115–120
  17. Henriques JP, Zijlstra F, Ottervanger JP, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J. 2002;23:1112–1117
  18. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 2001;344:1895–1903
  19. Antoniucci D, Rodriguez A, Hempel A, et al. A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction. J Am Coll Cardiol. 2003;42:1879–1885
  20. Sadeghi HM, Grines CL, Chandra HR, et al. Percutaneous coronary interventions in octogenarians. glycoprotein IIb/IIIa receptor inhibitors' safety profile. J Am Coll Cardiol. 2003;42:428–432
  21. Molinari G, Nicoletti I, De Benedictis M, et al. Safety and efficacy of the percutaneous radial artery approach for coronary angiography and angioplasty in the elderly. J Invasive Cardiol. 2005;17:651–654
  22. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218–2230
  23. Dudek D, Zmudka K, Witzenbichler B, et al. Impact of advanced age on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: The HORIZONS AMI trial. J Am Coll Cardiol. 2008;51:B67
  24. Zorman S, Zorman D, Noc M. Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty. Am J Cardiol. 2002;90:533–536
  25. Gyongyosi M, Domanovits H, Benzer W, et al. Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion — results of the Austrian multi-centre randomized ReoPro-BRIDGING study. Eur Heart J. 2004;25:2125–2133
  26. Gabriel HM, Oliveira JA, da Silva PC, da Costa JM, da Cunha JA. Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: results of the early ReoPro administration in myocardial infarction (ERAMI) trial. Catheter Cardiovasc Interv. 2006;68:218–224
  27. Ellis SG, Tendera M, de Belder MA, et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med. 2008;358:2205–2217
  28. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with st-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with st-elevation myocardial infarction, writing on behalf of the 2004 Writing Committee. Circulation. 2008;117:296–329
  29. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

☆ EUROTRANSFER Registry was an academic research project which was supported by a research grant from Eli Lilly and Company, Critical Care Europe, Geneva, Switzerland.

PII: S0167-5273(09)00158-2

doi: 10.1016/j.ijcard.2009.02.002

International Journal of Cardiology
Volume 143, Issue 2 , Pages 147-153 , 20 August 2010

Article Tools

* Image Usage & Resolution